Myelofibrosis: A Challenging Preclinical Model with an Unmet Clinical Need – Presentation by TD2

Time: 2:00 pm
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 1 PM


  • TD2 overview with updates in services and technology.
  • General overview of myelofibrosis clinically and preclinically. 
  • TD2 models for myelofibrosis and how they can be used to drive programs forward